← Open Payments lookup

GEETHU PHILIP: Open Payments

NPI 1992467849 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,421 in 57 payments from 11 companies in 2025. Trend: 2023 $720 · 2024 $884 · 2025 $1,421

Food & beverage: $1,421
CompanyPaymentsAmount
Madrigal Pharmaceuticals17$606
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$204
Gilead Sciences, Inc.10$198
ABBVIE INC.10$172
Intercept Pharmaceuticals, Inc.3$66
Ipsen Biopharmaceuticals, Inc2$46
Takeda Pharmaceuticals U.S.A., Inc.2$40
Eisai Inc.1$28
ORPHALAN INC1$27
Novo Nordisk Inc1$17

Products named: REZDIFFRA, XIFAXAN, MAVYRET, OCALIVA, IQIRVO, LIVTENCITY, Lenvima, CUVRIOR.

Industry payments across TX — which companies pay providers there.